Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Squibb: Looks Like a Good Value
Seeking Alpha
Monday, March 1, 2010 - 11:48am
tags:
Bristol-Myers Squibb
Should Generic Drugmakers Pay User Fees?
Pharmalot
Monday, March 1, 2010 - 11:01am
tags:
generics, user fees
OSI, Millipore takeover bids stoke biotech stocks
Marketwatch
Monday, March 1, 2010 - 11:00am
tags:
OSI Pharmaceuticals, Millipore, Astellas, drug stocks, M&A, Merck KGaA
Ariad cancer treatment gets 'orphan drug' status
Yahoo/AP
Monday, March 1, 2010 - 10:49am
tags:
orphan drugs, Ariad Pharmaceuticals, leukemia
Japan's Astellas bids $3.5 billion for OSI Pharma
Reuters
Monday, March 1, 2010 - 10:48am
tags:
OSI Pharmaceuticals, Astellas, M&A
Heart Association Finds Drug Risks "Inconclusive" After Taking $3.6M From Its Maker Glaxo
BNET Pharma
Monday, March 1, 2010 - 10:39am
tags:
Avandia, GSK, American Heart Association
Stronger Label for Biogen's Tysabri
Yahoo/Zacks.com
Monday, March 1, 2010 - 10:00am
tags:
Biogen Idec, Elan, Tysabri, multiple sclerosis
FDA accepts Vivus application for obesity drug
Marketwatch
Monday, March 1, 2010 - 9:57am
tags:
FDA, Vivus, obesity, Qnexa
Merck Announces Robust Integrated Pipeline With More Than 20 Medicines and Vaccines in Late-Stage Development
Yahoo
Monday, March 1, 2010 - 9:55am
tags:
Merck, pipelines
California County Sues Glaxo Over Avandia Risks
Pharmalot
Monday, March 1, 2010 - 9:54am
tags:
GSK, Avandia, diabetes, California, lawsuits
FDA Accepts VIAject NDA for Review
Yahoo
Monday, March 1, 2010 - 9:53am
tags:
Biodel, Viaject, NDA, FDA
Experimental Alzheimer's Drug Shows Promise
CNBC
Monday, March 1, 2010 - 9:52am
tags:
Alzheimer's disease, Pfizer, bapineuzumab, Wyeth
Merck KGaA to Buy Millipore for About $6 Billion
Bloomberg
Monday, March 1, 2010 - 9:50am
tags:
Merck KGaA, Millipore, Thermo Fisher, M&A
AstraZeneca to pay Merck $647M for drug interests
Yahoo/AP
Monday, March 1, 2010 - 9:31am
tags:
AstraZeneca, Merck, partnerships, Atacand, Lexxel, Plendil, Entocort
Gilead Science: Dominance in the HIV Market
Seeking Alpha
Monday, March 1, 2010 - 9:29am
tags:
Gilead Sciences, HIV, Quad
Daiichi Sankyo Unit to Sell Generic Drugs
WSJ Online
Monday, March 1, 2010 - 9:28am
tags:
generics, Daiichi Sankyo
KV Pharmaceutical Reaches Agreement with U.S. Department of Justice
PR-USA
Sunday, February 28, 2010 - 1:11pm
tags:
KV Pharmaceutical
Cannabis Science Moves Its FDA Clinical Trial Process Forward
Medical News Today
Sunday, February 28, 2010 - 1:09pm
tags:
Cannabis Science
Copaxone 15-Year Study In Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy And Safety
Medical News Today
Sunday, February 28, 2010 - 1:08pm
tags:
Copaxone, multiple sclerosis, Teva Pharmaceuticals
Lilly, Merck, Pfizer Team Up to Accelerate Cancer Research in Asia
Seeking Alpha
Sunday, February 28, 2010 - 1:03pm
tags:
Eli Lilly, Merck, Pfizer, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.